NCT06037668View on ClinicalTrials.gov

A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 8, 2023

Primary Completion Date

December 22, 2023

Study Completion Date

January 10, 2024

Conditions

Social Anxiety Disorder (SAD)

Interventions

DEVICE

BVR-100

Experimental self-guided VR intervention for the treatment of SAD

DEVICE

BES-100

Active at-home VR intervention comparator

Trial Locations (6)

32801

CNS Healthcare, Orlando

63304

Midwest Research Group, Saint Charles

68526

Alivation Health, LLC, Lincoln

84020

Cedar Clinical Research, Draper

02116

Curavit Clinical Research, Boston

02131

Boston Clinical Trials, Boston

All Listed Sponsors

collaborator

BehaVR LLC

INDUSTRY

lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT06037668 - A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder. | Biotech Hunter | Biotech Hunter